This is a StreetInsider.com Premium Only Page

Longeveron (LGVN) – Hot FDA News

Oct 5, 2023 07:09 AM Longeveron (LGVN) Climbs 45% Following Positive Top-Line Results for Lomecel-B

Mar 31, 2022 08:03 AM Longeveron (LGVN) Publishes Peer Reviewed Study of Phase 1 Trial Results of Lomecel-B for Alzheimer’s Disease in Alzheimer’s & Dementia®: The Journal of the Alzheimer’s Association

Aug 13, 2021 07:02 AM

Apr 13, 2021 09:15 AM

Mar 11, 2021 09:12 AM